Dublin, May 25, 2021 (GLOBE NEWSWIRE) The "Short-Read Sequencing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Short-Read Sequencing estimated at US$10.6 Billion in the year 2020, is projected to reach a revised size of US$20.4 Billion by 2027, growing at a CAGR of 9.9% over the period 2020-2027. Next-Generation Sequencing, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$13.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Sanger Sequencing segment is readjusted to a revised 10.6% CAGR for the next 7-year period.The U.S. Market is Estimated at $3.1 Billion, While China is Forecast to Grow at 9.3% CAGRThe Short-Read Sequencing market in the U.S. is estimated at US$3.1 Billion in the year 2020. China, the world`
Product News: Molzym announces FDA Breakthrough Device Designation for its molecular diagnostic test system
FDA Breakthrough Device Designation for Sepsis, Joint & Implant Infections, Infective Endocarditis, Bacterial Meningitis
13 May 2021
Molzym’ s unique technology for molecular microbial diagnostics was granted Breakthrough Device Designation (BDD) by the FDA in light of its capacity to aid the diagnosis of Bloodstream Infection/Sepsis, Joint and Implant Infections, Infective Endocarditis, and Bacterial Meningitis as an adjunct to the current standard of care.
The FDA BDD Program aims at providing patients and health care providers with timely access to these breakthrough medical devices by speeding up their development, assessment, and review, while preserving the statutory standards for premarket approval. Under the BDD, the FDA will provide Molzym with interactive communication and priority review towards commercialization decisions.
Search jobs 18-Feb-2021 Sequencing Reagents Market Share & Size, Future Growth, Trends Evaluation, Industry Demands, Regional Analysis and Forecast to 2027
DBMR recently published a detailed study of over 350+ pages in its repository on
Sequencing Reagents Market covering interesting aspects of market with supporting development scenario till 2027. The study provides market size break-up by revenue and volume for emerging countries and important business segments along with commentary on trending factors, growth drivers. To perform competitive analysis, a range of strategies of the major players in the market have been believed that include new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others which lead to an ascend of their footprints in the market. Additionally, this report gives Sequencing Reagents Market size, trends, share, growth, and cost structure and drivers analysis. The stud
Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Lynparza: IDMC recommend early analysis of OlympiA investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.